DVAX
DYNAVAX TECHNOLOGIES CORP
undefined Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$27.3M
↑ 527.4%
Operating Income
$-4122000
↑ 88.9%
Revenue
$277.2M
↑ 19.4%
EPS (Diluted)
$0.20
↑ 500.0%
Total Assets
$986.3M
↓ 1.1%
Cash & Equivalents
$95.9M
↓ 36.2%
Total Liabilities
$389.5M
↑ 3.8%
Shareholders' Equity
$596.8M
↓ 4.1%

Recent SEC Filings

Form Type Filed Date Link
15-12G 2/20/2026 View on SEC
EFFECT 2/13/2026 View on SEC
4 2/11/2026 View on SEC
SCHEDULE 13G/A 2/11/2026 View on SEC
S-8 POS 2/10/2026 View on SEC
S-8 POS 2/10/2026 View on SEC
S-8 POS 2/10/2026 View on SEC
S-8 POS 2/10/2026 View on SEC
S-8 POS 2/10/2026 View on SEC
S-8 POS 2/10/2026 View on SEC

Company Information

Field Value
Ticker DVAX
Company Name DYNAVAX TECHNOLOGIES CORP
CIK 1029142
Sector Pharmaceutical Preparations
Industry Large accelerated filer
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 5108485100